Ruidong Xue
Overview
Explore the profile of Ruidong Xue including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
688
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Teo J, Chen Z, Chen W, Tan R, Cao Q, Chu Y, et al.
J Exp Med
. 2024 Dec;
222(1).
PMID: 39636298
Tumor-associated neutrophils (TANs) are heterogeneous; thus, their roles in tumor development could vary depending on the cancer type. Here, we showed that TANs affect metabolic dysfunction-associated steatohepatitis hepatocellular carcinoma (MASH-related...
2.
Liu H, Gao J, Feng M, Cheng J, Tang Y, Cao Q, et al.
Cancer Cell
. 2024 May;
42(6):1067-1085.e11.
PMID: 38759655
In acral melanoma (AM), progression from in situ (AMis) to invasive AM (iAM) leads to significantly reduced survival. However, evolutionary dynamics during this process remain elusive. Here, we report integrative...
3.
Chen L, Zhang C, Xue R, Liu M, Bai J, Bao J, et al.
Nature
. 2024 Feb;
627(8004):586-593.
PMID: 38355797
Over half of hepatocellular carcinoma (HCC) cases diagnosed worldwide are in China. However, whole-genome analysis of hepatitis B virus (HBV)-associated HCC in Chinese individuals is limited, with current analyses of...
4.
Deng Y, Chen P, Xiao J, Li M, Shen J, Qin S, et al.
Nucleic Acids Res
. 2023 Sep;
52(D1):D1407-D1417.
PMID: 37739405
Advances in sequencing and imaging technologies offer a unique opportunity to unravel cell heterogeneity and develop new immunotherapy strategies for cancer research. There is an urgent need for a resource...
5.
Xiang X, Hao Y, Cheng C, Hu H, Chen H, Tan J, et al.
Hepatology
. 2023 Jul;
79(3):650-665.
PMID: 37459556
Background And Aims: Hepatoblastoma (HB) is the most common liver cancer in children, posing a serious threat to children's health. Chemoresistance is the leading cause of mortality in patients with...
6.
Cao Q, Xue R, Zhang N
Chin J Cancer Res
. 2023 Jul;
35(3):299-315.
PMID: 37440828
Objective: Cancer immunotherapy has made remarkable advances in recent years, but its effectiveness in treating gastric cancer is often limited by the complexity of the tumor microenvironment and the lack...
7.
Wang Y, Xiang X, Chen H, Zhou L, Chen S, Zhang G, et al.
Cell Rep Med
. 2023 May;
4(5):101044.
PMID: 37196629
Erythroblastic islands (EBIs) are the specialized structures for erythropoiesis, but they have never been found functional in tumors. As the most common pediatric liver malignancy, hepatoblastoma (HB) requires more effective...
8.
Xue R, Zhang Q, Cao Q, Kong R, Xiang X, Liu H, et al.
Nature
. 2022 Nov;
612(7938):141-147.
PMID: 36352227
The heterogeneity of the tumour immune microenvironment (TIME), organized by various immune and stromal cells, is a major contributing factor of tumour metastasis, relapse and drug resistance, but how different...
9.
Guo L, Yi X, Chen L, Zhang T, Guo H, Chen Z, et al.
Gastroenterology
. 2021 Sep;
162(1):238-252.
PMID: 34481846
Background & Aims: Copy number alterations (CNAs), elicited by genome instability, are a major source of intratumor heterogeneity. How CNAs evolve in hepatocellular carcinoma (HCC) remains unknown. Methods: We performed...
10.
Liu Z, Wang A, Pu Y, Li Z, Xue R, Zhang C, et al.
Oncogene
. 2021 Jul;
40(38):5705-5717.
PMID: 34326469
Hepatoid adenocarcinoma of the stomach (HAS), a rare subtype of gastric cancer (GC), has a low incidence but a high mortality rate. Little is known about the molecular features of...